HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.
Zhou Y, Jin X, Yu H, Qin G, Pan P, Zhao J, Chen T, Liang X, Sun Y, Wang B, Ren D, Zhu S, Wu H.
Zhou Y, et al. Among authors: ren d.
Theranostics. 2022 Jan 31;12(5):2080-2094. doi: 10.7150/thno.69444. eCollection 2022.
Theranostics. 2022.
PMID: 35265200
Free PMC article.